RxDoctor Payments Data

Carolyn Behling

Gerontology · Columbus, INNPI 1053052159

Payments from drug & device makers

What this record shows

Boston Scientific accounts for 73.4% of it on its own, with 11 other manufacturers making up the rest. Among gerontology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,698in general payments, 2019–2025

Across 63 payments — averaging $74.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Novartis$187
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$167
  • Medtronic$166
  • Edwards Lifesciences$160
  • Abiomed$131
  • plus $440 from 6 others

What the payments were for

  • Travel & lodging$2,34150%
  • Food & beverage$2,35750%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,698 in reported general payments places this provider in the 90th percentile of 230 gerontology providers in Indiana.

See all gerontology providers in Indiana

Medicare billing

Part B allowed, 2024
$33,904
Medicare patients
253
Services billed
393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban145$148,428
EntrestoSacubitril/Valsartan40$52,030
BrilintaTicagrelor54$46,726
XareltoRivaroxaban20$21,586
JardianceEmpagliflozin22$21,297
Repatha SureclickEvolocumab16$18,532
Metoprolol Succinate289$3,566
Losartan Potassium161$1,055
Atorvastatin Calcium106$979
Rosuvastatin Calcium104$962
ClopidogrelClopidogrel Bisulfate81$952
Amiodarone Hcl21$703
Diltiazem 24hr Er (Cd)Diltiazem Hcl31$642
Ezetimibe49$636
Torsemide27$569

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$63$148,428145 claims
NovartisEntresto$187$52,03040 claims
AstraZenecaBrilinta$33$46,72654 claims
Boehringer IngelheimJardiance$92$21,29722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 230 gerontology providers in Indiana.

Other gerontology in Columbus

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →